Modelling the strategic use of antiretroviral therapy for the treatment and prevention of HIV.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24167450.
- Also identified by DOI 10.1371/journal.pmed.1001535 and PMC identifier 3805474.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nathan Ford and Gottfried Hirnschall reflect on recent research by Jan Hontelez and colleagues published in this week's PLOS Medicine. The authors argue that the future HIV modeling efforts should focus on helping programs make choices about which interventions need to be prioritized in order to achieve the levels of enrollment and retention in care required to maximize the prevention benefit of ART. Please see later in the article for the Editors' Summary.
Medical subject headings
- HIV Infections
- Models, Theoretical